Exchange: NASDAQ·Updated 03:21 PM EDT
IMRN logo

IMRNIMMURON Ltd/S ADR

$1.13
$0.0899
(7.37%)
Today
Mkt Cap$9.85M
Vol40,821.00
News
all
press releases
Immuron Stock Rallies After CEO Dismisses US Pharma Tariff Impact, Provides Positive Pipeline Updates
CEO Steven Lydeamore stated that while Travelan is imported into the U.S. from Australia, it is not a pharmaceutical product but a dietary supplement, and is therefore not expected to be impacted by U.S. pharmaceutical tariffs.
Stocktwits
<
...
1
>

Advertisement|Remove ads.